From their beginnings as a treatment for type 2 diabetes, GLP-1 receptor agonists such as the semaglutide drugs Ozempic and Wegovy and the tirzepatide drugs Mounjaro and Zepbound have seen an explosion in use, most popularly for weight loss
For this study, we used the Vienna Idiopathic Intracranial Hypertension (VIIH) database, a cohort comprising 151 patients with definite IIH according to modified Friedman criteria [12]
The Risk All Four Medications Share And How LeanMD Addresses It Regardless of which GLP-1 weight loss medication you take, all four carry the same critical risk: loss of lean muscle mass alongside fat
Meal Timing : Smaller, frequent meals often improve tolerability compared to large portions
The finding was replicated by tirzepatide maker Eli Lilly, who carried out tests on the impact of mixing tirzepatide and B12 and released a statement underscoring that the clinical consequences of the new molecule are not known
Gandasi, N